(formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women. “This guideline from an organization with a robust technology assessment process expands our ability to truly change the standard of care and helps advance our commitment to making OVA1® accessible to ALL women.”Ībout Aspira Women’s Health Inc.Aspira Women’s Health Inc. “We are excited to provide access to OVA1plusTM, to such a large segment of the population,” said Valerie Palmieri, President and CEO of Aspira Women’s Health Inc. provider for Aspira’s proprietary OVA1® test, an FDA-cleared, ACOG recommended, and Medicare covered ovarian cancer risk assessment tool for women with a pelvic mass. Aspira Labs, Inc., a subsidiary of Aspira Women’s Health, is the only U.S. Recent positive coverage additions for OVA1®, such as New York State Medicaid, coupled with peer-reviewed publications documenting OVA1®’s superior clinical performance as compared to CA125, especially among Black women, has resulted in a dramatic increase in the number of women who have access to the OVA1® technology. The guidelines also include OVA1® for the determination of the required surgical approach, operator expertise and level of care for an adnexal mass. The OVA1® test is now included in AIM’s guidelines for the preoperative evaluation of an adnexal mass when it is indeterminate based on clinical and complete pelvic ultrasound evaluation. As one of the nation’s leading specialty benefits management firms, AIM helps improve the quality of care and reduces the cost for many of the most complex tests and treatments. AIM’s mission is to promote appropriate, safe, and affordable health care. AIM Specialty Health is a member of the Anthem Blue Cross Blue Shield family of companies and serves as a specialty benefits management company working with many of the nation’s largest health care organizations. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medically necessary according to AIM Specialty Health’s Clinical Appropriateness Guidelines. In animal nutrition and health, we develop core vitamins, premix solutions, and specialty feed additive solutions, including mycotoxin risk management solutions and diagnostics, that are able lead a robust and achievable transformation worldwide in sustainable food production.AIM is a wholly owned subsidiary of Anthem, Inc., serving more than 50 million members across 50 states, D.C., and US territories.ĪUSTIN, Texas, J(GLOBE NEWSWIRE) - Aspira Women’s Health Inc. We serve the personal care, home care and fine fragrance markets too with solutions including UV filters, peptides and polymers.įood & beverage ingredients include (specialty food enzymes, cultures and probiotics, as well as bio-preservation, sugar reduction, and savory taste solutions, so consumers don’t have to choose between taste, texture and health. Looking and feeling good is important for people everywhere, but health & beauty isn’t purely about the aesthetics. In human nutrition we provide customized quality solutions that support the well-being of people at every life stage including nutritional ingredients, consumer-branded products, and personalized nutrition. We focus on clearly defined areas where we can contribute to healthier lives. We aspire to be a company for all, creating value for all our stakeholders - customers, employees, shareholders, and society-at-large - and building a stronger legacy and a brighter future for generations to come. We aim to generate profitable growth while at the same time having a positive impact on the world, creating a fairer, more prosperous, and more sustainable society. We use our bright science to deliver positive transformations at scale for as many people as possible today and for generations to come, operating within the constraints of the world’s finite resources. Annual General Meeting of Shareholders 2023
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |